Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects
Recruiting
Phase 1
Interventional Study
Pharmacokinetics
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 55
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 48 (estimated)
- Sponsor
- Modern Biosciences Ltd · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A DDI study consisting of 4 parts conducted as an open label, fixed sequence study in healthy adult subjects.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Principal Inclusion Criteria:
Healthy, adult, male or female of non childbearing potential 18 to 55 years of age.
Principal Exclusion Criteria:
History or presence of clinically significant medical or psychiatric condition or disease in the opinion of the PI or designee.
History of any illness t…
Contacts